Patent · US Active

Oxazine derivatives and their use in the treatment of disease

US9284284B2 · kind B2 · utility

4Cited by

0References

19Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Konstanze Hurth · Rixheim, FR
Sebastien Jacquier · Hégenheim, FR
Rainer Machauer · Glückstadt, DE
Heinrich Rueeger · Interlaken, CH
Marina Tintelnot-Blomley · Maulburg, DE
Siem Jacob Veenstra · Basel, CH
Markus Voegtle · Lörrach, DE

Key dates

Filing date	Oct 11, 2012
Grant date	Mar 15, 2016
Priority date	—
Expiry date	Nov 24, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to novel oxazine derivatives of formula (I), and pharmaceutically acceptable salts thereof, in which all of the variables are as defined in the specification, pharmaceutical compositions thereof, combinations thereof, and their use as medicaments, particularly for the treatment of Alzheimer's Disease or diabetes via inhibition of BACE-1 or BACE-2.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.